• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2016

View Archived Issues

[11C]AS-2471907: a radioligand for PET imaging of brain 11beta-HSD1

Read More

Changes in absolute lymphocyte counts following up to 8 years of tofacitinib treatment

Read More

Galapagos offers R&D update

Read More

PSMA-ADC shows no activity in patients with progressive glioblastoma

Read More

Capricor Therapeutics reports preliminary data from study of CAP-1002 in heart failure

Read More

Phase III KEYNOTE-24 study of Keytruda in advanced NSCLC meets primary endpoint

Read More

European Commission approves Gazyvaro in follicular lymphoma

Read More

Astellas Pharma and Kotobuki Pharmaceutical patent leucyl-cystinyl aminopeptidase antagonists

Read More

Eli Lilly discloses EZH2 inhibitors

Read More

C&C Research Laboratories describes STAT3 inhibitors

Read More

Sagent Pharmaceuticals enters deal to acquire ANDAs from Teva

Read More

Shionogi develops P2X3 and/or P2X2/3 receptor antagonists

Read More

Ono Pharmaceutical presents S1P5 receptor agonists

Read More

RPC-8844 demonstrates promising efficacy in mouse models of type 2 diabetes

Read More

Final patient enrolled in phase IIa trial of T3D Therapeutics' T3D-959

Read More

ChemoCentryx reports topline results from CLASSIC study of CCX-168

Read More

Tri-I TDI expands relationship with Takeda into antibody drug discovery

Read More

Cantabio Pharmaceuticals enters agreement to evaluate chaperone drug candidates for PD

Read More

Nemus Bioscience's THC prodrug superior in animal models of IOP

Read More

Clinical data for GS-5745 in rheumatoid arthritis patients

Read More

Phase III trial of omadacycline in ABSSSI meets primary and secondary endpoints

Read More

Celgene joins DNDi's Neglected Tropical Diseases Drug Discovery Booster consortium

Read More

Kissei Pharmaceutical launches Glufast orally disintegrating tablets in Japan

Read More

FcgammaRIIb may predict time to treatment in CLL

Read More

Kiyatec collaborates with Mayo Clinic in ovarian cancer

Read More

Miraca Life Sciences launches InformTx therapeutic drug monitoring for IBD

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 7, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • 3D rendering of a molecular glue mediating the interaction between two proteins

    With surface mimicry, molecular glues shed hairpin need

    BioWorld Science
    Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe